EDGAR Verified
Primary Source · SEC.gov

EquityZen Growth Technology Fund LLC - Series 1571

CIK 0001957855Single-Deal SPV2023 vintage506(b), 3(c)(1)

Raised

$196K

Investors

10

Min Invest

$10,003

AltStreet Analysis

·

Generated from EDGAR primary sources

EquityZen Growth Technology Fund LLC - Series 1571 is a Delaware-based pooled investment fund that raised $196K from 10 investors with a $10K minimum investment, filed February 8, 2023. The offering relies on Regulation D Rule 506(b) and Investment Company Act Section 3(c)(1) exemptions. This is part of the EquityZen platform, which operates 1,889 related EDGAR entities focused on pre-IPO secondary market access.

This pre-IPO fund offering uses the standard 506(b)/3(c)(1) exemption structure common to private secondary market vehicles, with a $10K minimum that positions it in the accessible end of alternative investments. The $19.6K average investor commitment reflects the retail-accessible secondary share model typical of pre-IPO platform funds.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001957855
Entity NameEquityZen Growth Technology Fund LLC - Series 1571
Exemption506(b), 3(c)(1)
First Sale Date
Filing DateFebruary 8, 2023
Accession Number0001957855-23-000001
Total Amount Sold$196K
Total Investors10
Minimum Investment$10,003
Securities TypeEquity, Pooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

EquityZen Advisors LLC

Executive Officer, Director · New York, NY

Philip Haslett

Executive Officer, Director · New York, NY

Eric Bernstein

Executive Officer, Director · New York, NY

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.